Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).

Literature DB >> 16448783

The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).

Jon O Ebbert¹, Christi A Patten, Darrell R Schroeder.

Abstract

Few nicotine dependence measures have been developed for smokeless tobacco (ST) users. Existing measures are limited by the requirement to rate the nicotine content of ST brands for which data is scarce or non-existent. We modified the Fagerström Test for Nicotine Dependence (FTND) for ST users, referred to this scale as the FTND-ST, and evaluated its characteristics in a population of 42 ST users. The correlation between the FTND-ST total score and the serum cotinine concentrations was 0.53 (p<0.001). Internal consistency reliability assessed using the coefficient alpha was 0.47. Correlations and the coefficient alpha are similar to those reported for commonly used nicotine dependence measures. Development and refinement of nicotine dependence measures for ST users are essential steps in order to advance the field of ST research.

Entities: Chemical Species

Mesh：

Substances：

Year: 2006 PMID： 16448783 PMCID： PMC1618870 DOI： 10.1016/j.addbeh.2005.12.015

Source DB: PubMed Journal: Addict Behav ISSN： 0306-4603 Impact factor: 3.913

15 in total

Review 1. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors: K O Fagerstrom; N G Schneider
Journal: J Behav Med Date: 1989-04

Review 2. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors: N L Benowitz
Journal: N Engl J Med Date: 1988-11-17 Impact factor: 91.245

3. Relationship between nicotine tolerance questionnaire scores and plasma cotinine.

Authors: C S Pomerleau; O F Pomerleau; M J Majchrzak; D D Kloska; R Malakuti
Journal: Addict Behav Date: 1990 Impact factor: 3.913

4. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day.

Authors: T F Heatherton; L T Kozlowski; R C Frecker; W Rickert; J Robinson
Journal: Br J Addict Date: 1989-07

5. Some methodological cautions in the use of the Tolerance Questionnaire.

Authors: E Lichtenstein; R J Mermelstein
Journal: Addict Behav Date: 1986 Impact factor: 3.913

6. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors: K O Fagerström
Journal: Addict Behav Date: 1978 Impact factor: 3.913

7. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.

Authors: Patricia Richter; Francis W Spierto
Journal: Nicotine Tob Res Date: 2003-12 Impact factor: 4.244

8. Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.

Authors: Jon O Ebbert; Lowell C Dale; Liza M Nirelli; Darrell R Schroeder; Thomas P Moyer; Richard D Hurt
Journal: Addict Behav Date: 2004-02 Impact factor: 3.913

9. Residential treatment for smokeless tobacco use: a case series.

Authors: Jon O Ebbert; Lowell C Dale; Kristin S Vickers; Thomas R Gauvin; Nadene E Bunge; Richard D Hurt
Journal: J Subst Abuse Treat Date: 2004-06

10. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.

Authors: Thomas P Moyer; Joel R Charlson; Robert J Enger; Lowell C Dale; Jon O Ebbert; Darrell R Schroeder; Richard D Hurt
Journal: Clin Chem Date: 2002-09 Impact factor: 8.327

68 in total

1. Smokeless tobacco cessation cluster randomized trial with rural high school males: intervention interaction with baseline smoking.

Authors: Margaret M Walsh; Timothy J Langer; Niall Kavanagh; Chuck Mansell; William MacDougal; Catherine Kavanagh; Stuart A Gansky
Journal: Nicotine Tob Res Date: 2010-05-03 Impact factor: 4.244

2. A pilot study to assess smokeless tobacco use reduction with varenicline.

Authors: Jon O Ebbert; Ivana T Croghan; Frederick North; Darrell R Schroeder
Journal: Nicotine Tob Res Date: 2010-08-19 Impact factor: 4.244

3. Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.

Authors: Sonali Jhanjee; Raka Jain; Veena Jain; Tina Gupta; Swati Mittal; Patricia Goelz; Robert A Schnoll
Journal: J Psychoactive Drugs Date: 2015-08-28

4. Cognitive Behavioural Therapy versus Basic Health Education for Tobacco Cessation among Tobacco Users: A Randomized Clinical Trail.

Authors: Mitali Raja; Sabyasachi Saha; Shafaat Mohd; Ridhi Narang; L Vamsi Krishna Reddy; Minti Kumari
Journal: J Clin Diagn Res Date: 2014-04-15

5. The interrelationship between urinary cotinine and nicotine dependence among tobacco users in an Indian de-addiction centre: A cohort pilot study.

Authors: Nalini M Vinoth Kumar; Shahnawaz Khijmatgar; Avidyuti Chowdhury; Martin Gootveld; Edward Lynch; Chitta Chowdhury
Journal: J Oral Biol Craniofac Res Date: 2019-07-15